Dyadic(US:DYAI) Newsfilter·2024-05-30 20:30Core Insights - Dyadic International, Inc. is a biotechnology company focused on large-scale protein manufacturing for vaccines and therapeutics, as well as non-pharmaceutical applications like food and wellness [3][4]. Event Participation - Dyadic management will attend several industry events in June 2024, including BIO 2024 in San Diego from June 3-6, Future Food Tech-Alt Proteins in Chicago on June 17-18, and the 2024 NIIMBL National Meeting in Washington, DC from June 25-27 [2]. Technology and Platforms - The company utilizes the Thermothelomyces heterothallica fungus for its gene expression and protein production platforms, with the C1-cell protein production platform being a key technology for biologic vaccines and drugs [4]. - Dyadic has developed the Dapibus™ platform for the rapid and cost-effective production of proteins and biologic products for non-pharmaceutical uses [4]. Product Pipeline - Dyadic is advancing its proprietary microbial platform technologies, including the DYAI-100 COVID-19 vaccine candidate, and is focused on developing biologic vaccines, antibodies, and other biological products [5].